Migraine as a vascular risk factor;La migraña como factor de riesgo vascular

Revista de Neurologia

Volumn 55, Issue 6, 2012, Pages 349-358

  Larrosa Campo, Davinia ^a   Carbajo, César R ^a   Para Prieto, Marta ^a   Calleja Puerta, Sergio ^a   Cernuda Morollón, Eva ^a   Pascual, Julio ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Cardiovascular disease; Migraine; Stroke; White matter lesions

Indexed keywords

ARTERY DISSECTION; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; HEREDITY; HUMAN; HYPERCOAGULABILITY; MIGRAINE; PATENT FORAMEN OVALE; REVIEW; RISK FACTOR; VASCULAR SMOOTH MUSCLE; WHITE MATTER;

EID: 84867666292     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5506.2012194     Document Type: Review

References (61)

1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, second edition. Cephalalgia 2004; 24 (Suppl 1): 9-160.
2. Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women. Associated risk factors. JAMA 1975; 231: 718-22.
3. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010; 123: 612-24.
4. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330: 63.
5. Becker C, Brobert GP, Almqvist PM, Johansson S, Jick SS, Meier CR. Migraine and the risk of stroke, TIA or death in the UK. Headache 2007; 47: 1374-84.
6. Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339: 3914.
7. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, et al. Migraine and cardiovascular disease. A population-based study. Neurology 2010; 74: 628-35.
8. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, et al. Headache, cerebrovascular symptoms, and stroke. The Atherosclerosis Risk in Communities Study. Neurology 2005; 64: 1573-7.
9. Gudmundsson LS, Scher AI, Aspelund T, Eliasson JH, Johannsson M, Thorgeirsson G, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 2010; 341: 3966.
10. Schürks M, Rist PM, Shapiro RE, Kurth T. Migraine and cardiovascular disease: a systematic review and meta-analysis. Cephalalgia 2011; 31: 1301-14.
11. Bigal ME. Migraine and cardiovascular disease. Arq Neuropsiquiatr 2011; 69: 122-9.
12. Kurth T, Schürks M, Logroscino G, Gaziano M, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008; 337: 636.
13. MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, et al. Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women Study. Stroke 2007; 38: 2438-45.
14. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006; 296: 283-91.
15. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007; 167: 795-801.
16. Kurth T, Schürks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009; 73:581-588.
17. Kurth T, Kase CS, Schürks M, Tzourio C, Buring JE. Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ 2010; 341: 3659.
18. Féré C. Contribution à l'étude de la migraine ophtalmique. Rev Med 1881; 1: 625-49.
19. Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005; 4: 533-42.
20. Wolf ME, Szabo K, Griebe M, Förster A, Gass A, Hennerici MG, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011; 76: 1911-7.
21. Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, et al. Headache, migraine, and structural brain lesions and function: population based epidemiology of vascular ageing-MRI study. BMJ 2011; 342: 7357.
22. Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, Eiriksdottir G, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009; 301: 2563-70.
23. Kruit MC, Van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291: 427-34.
24. Kruit MC, Launer LJ, Ferrari MD, Van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005; 128: 2068-77.
25. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities. A meta-analysis. Arch Neurol 2004; 61: 1366-8.
26. Partida-Medina LR, Hernández-Cruz EM. La función del endotelio en la migraña. Rev Mex Neuroci 2010; 11: 212-7.
27. Lee ST, Chu K, Jung KH, Kim DH, Kim EH, Choe VN, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008; 70: 1510-7.
28. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease. Possible mechanisms of interaction. Neurology 2009; 72: 1864-71.
29. Vargas BB, Dodick DW, Wingerchuk DM, Demaerschalk BM. Migraine with and without aura and risk for cardiovascular disease. Curr Atheroscler Rep 2008; 10: 427-33.
30. Tietjen GE, Herial NA, White L, Utley C, Kosmyna JM, Khuder SA. Migraine and biomarkers of endothelial activation in young women. Stroke 2009; 40: 2977-82.
31. Tietjen GE. Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia 2007; 27: 981-7.
32. Pezzini A, Del Zotto E, Giossi A, Volonghi I, Grassi M, Padovani A. The migraine-ischemic stroke connection: potential pathogenic mechanisms. Curr Mol Med 2009; 9: 215-26.
33. Tietjen GE. The risk of stroke in patients with migraine and implications for migraine management. CNS Drugs 2005; 19: 683-92.
34. Martínez-Sánchez P, Martínez-Martínez M, Fuentes B, Cuesta MV, Cuéllar-Gamboa L, Idrovo-Freire L, et al. Migraine and hypercoagulable states in ischemic stroke. Cephalalgia 2011; 31: 1609-17.
35. Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012; 11: 92-100.
36. Ming X, Yacoub H, Khanna A, Wagner GC. Two young patients with stroke in conjunction with migraineus headache. Open Neurol J 2010; 4: 111-6.
37. Del Zotto E, Pezzini A, Giossi A, Volonghi I, Padovani A. Migraine and ischemic stroke: a debated question. J Cereb Blood Flow Metab 2008; 28: 1399-421.
38. Napoli R, Guardasole V, Zarra E, Matarazzo M, D'Anna C, Saccà F, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 2009; 72: 2111-4.
39. Pezzini A, Del Zotto E, Giossi A, Volonghi I, Costa P, Dalla Volta G, et al. The migraine-ischemic stroke relation in young adults. Stroke Res Treat 2010; 2011: 304921.
40. Schürks M, Zee RY, Buring JE, Kurth T. ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology 2009; 72: 650-6.
41. Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Volta GD, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a strokesubtype effect. Stroke 2007; 38: 3145-51.
42. Schürks M, Zee RY, Buring JE, Kurth T. Interrelationships between the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 2008; 7: 505-13.
43. Schürks M, Buring JE, Ridker PM, Chasman DI, Kurth T. Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS One 2011; 6: 22106.
44. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008; 28: 531-40.
45. Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 2007; 20: 310-9.
46. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Stroke 2002; 33: 706-11.
47. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13: 102-6.
48. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 2006; 66: 765-7.
49. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention with STARFlex Technology (MIST) Trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117: 1397-404.
50. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62: 1399-401.
51. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004; 62: 1439-40.
52. Butera G, Biondi-Zoccai GG, Carminati M, Caputi L, Usai S, Bussone G, et al. Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? Catheter Cardiovascular Interv 2010; 75: 494-504.
53. Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, et al. Lack of association between migraine headache and patent foramen ovale. Results of a case-control study. Circulation 2010; 121: 1406-12.
54. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine. The GEM population-based study. Neurology 2005; 64: 614-20.
55. Winsvold BS, Hagen K, Aamodt AH, Stovner LJ, Holmen J, Zwart JA. Headache, migraine and cardiovascular risk factors: the HUNT study. Eur J Neurol 2011; 18: 504-11.
56. Rubinstein SM, Peerdeman SM, Van Tulder MW, Riphagen I, Haldeman S. A systematic review of the risk factors for cervical artery dissection. Stroke 2005; 36: 1575-80.
57. Rist PM, Diener HC, Kurth T, Schürks M. Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia 2011; 31: 886-96.
58. Artto V, Metso TM, Metso AJ, Putaala J, Haapaniemi E, Wessman M, et al. Migraine with aura is a risk factor for cervical artery dissection: a case-control study. Cerebrovasc Dis 2010; 30: 36-40.
59. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine. The risks of stroke, cardiovascular disease, and death in practice. Neurology 2004; 62: 563-8.
60. Wammes-Van der Heijden EA, Rahimtoola H, Leufkens HG, Tijssen CC, Egberts AC. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006; 67: 1128-34.
61. Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache 2004; 44: 642-51.